This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

UPTRAVI® (selexipag)

Medical Information

Storage and Handling of the Intravenous Formulation of UPTRAVI

Last Updated: 04/10/2025

SUMMARY

  • UPTRAVI for injection is available in cartons containing 1 single-dose vial and should be stored at 2°C to 8°C (36°F to 46°F).1
  • Please refer to the HOW SUPPLIED/STORAGE AND HANDLING section of the full Prescribing Information.1

PRODUCT LABELING

Storage and Handling

UPTRAVI for injection, for intravenous use, is supplied in a 10 mL type I glass vial closed by a stopper and sealed with an aluminum flip-off button, containing 1800 mcg of selexipag.1

UPTRAVI for injection is available in cartons containing 1 single-dose vial.1

Store the original carton containing the glass vial in a refrigerator at 2°C to 8°C (36°F to 46°F) until use in order to protect from light.1

Literature Search

A literature search of MEDLINE®, EMBASE®, BIOSIS Previews®, DERWENT® (and/or other resources, including internal/external databases) was conducted on 07 April 2025.

 

References

1 UPTRAVI (selexipag) [Prescribing Information]. Titusville, NJ: Actelion Pharmaceuticals US, Inc;https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/UPTRAVI-pi.pdf